The first batch of triple vaccine Jiss Flu (more than 30,000 doses) from South Korea already passed the lab tests and supplied to Ukrainian pharmacy stores. The tetravalent Vaxigrip Tetra from France is supposed to be available for sale in pharmacy shops in about two weeks. Influvac vaccine from the Netherlands will reach the sales soon after passing the lab tests as well.
The Public Health Centre of Ukraine's Healthcare Ministry claims that last epidemiological season, the disease struck 4.9 million people (12 percent of Ukraine's population), 63 percent of those were children up to 17 years old. 71 cases proved lethal. During the last epidemiological season, Ukraine got 500,000 doses of vaccine; 238,000 people got inoculated, 10.5 percent of those where children.